http://www.fda.gov/NewsEvents/Newsroom/ ... 409950.htm
That should be good for some exciting after-hours trading among today's sleep-walking day-traders, eh?
According to some possibly-biased (ain't most all of 'em these days?) scientists:
Sounds like maybe a new useful tool, at least for some relatively rare situations? Dunno. Likely to get overused, either way, in my opinion."Suvorexant’s mechanism of action differs from that of the benzodiazepines and nonbenzodiazepines; it has no effect on GABA. Instead of promoting sleep, it inactivates wakefulness. Adverse effects commonly observed with benzodiazepines and nonbenzodiazepines are virtually eliminated. As a result, suvorexant can be used daily on a long-term basis with no risk of rebound insomnia or physical dependence." -- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989084/
(Full disclosure: I do own a few shares of Merk. But I don't think that qualifies this post as spam.)